Clinical Trials Directory

Trials / Unknown

UnknownNCT01605110

Effects of Hyperbaric Oxygen Therapy on Surgical Wound Healing

Effects of HBOT for Edema/Ecchymosis After Upper Eyelid Blepharoplasty (Single Site Study)

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
164 (estimated)
Sponsor
Restorix Research Institute, LLLP · Academic / Other
Sex
All
Age
40 Years – 85 Years
Healthy volunteers
Accepted

Summary

The aim of this study is to test the effect of Hyperbaric Oxygen Therapy) HBOT (100% oxygen; 2.0 ATA; 90 minute total exposure) and compare against a hyperbaric sham treatment (HBST) (patient's breathing room air; 2.0 ATA; 90 minute exposure) in reducing edema and ecchymosis. HBOT will be applied as a single pre-operative and a single post-operative treatment for patients undergoing eyelid surgery. Briefly, patients will be exposed to HBOT 2-4 hours prior to undergoing surgery, 2-4 hours post-surgery and healing will be assessed at day 3, 10, 21, 30 \& 90 days after surgery. Edema and ecchymosis will be assessed in a time series to determine the extent that HBOT reduces these clinical signs. The primary null hypothesis to test will be that no differences in scores will exist between treatment and control at day 3, 10 \& 21 post-surgery. A secondary null hypothesis to test is the time required to change a score will be no different between the two groups. HBOT=hyperbaric oxygen therapy; HBST=hyperbaric sham treatment

Conditions

Interventions

TypeNameDescription
DRUGHyperbaric oxygen treatmentPatients that volunteer to participate in this study will be exposed to two treatments (one before surgery; one after surgery) of 100% oxygen at 2.0 atmospheres absolute (ATA) inside mono-place chambers for 90 minutes (at depth).
DRUGAir shamPatients that volunteer to participate in this study will be exposed to two treatments (one before surgery; one after surgery) of medical grade air (21%oxygen; sham) at 1.2 ATA inside mono-place chambers for 90 minutes.

Timeline

Start date
2011-08-01
Primary completion
2013-11-01
Completion
2013-12-01
First posted
2012-05-24
Last updated
2012-12-05

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01605110. Inclusion in this directory is not an endorsement.